D. Phillip Cox

D. Phillip Cox has held a variety of roles within the pharmaceutical industry since 1985. D. Phillip began their career at Lonza, where they served as Manager of Process Improvement. In 1999, they moved to Noramco Inc., where they were the Director of Chemistry Services. In 2004, they were promoted to Chief Scientist at Noramco. In 2016, they became the CEO and Chairman of Axxia Pharmaceuticals LLC. In 2017, they established Andrem LLC as a Sole Proprietor. Most recently, in 2018, they were appointed as the VP of Commercial Manufacturing at Enterin Inc.

D. Phillip Cox obtained a Doctor of Philosophy (Ph.D.) in Organic Chemistry from Flinders University between 1975 and 1978.